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The human cell surface receptor for transferrin is a transmembrane phosphoglycoprotein composed of two 
disulphide linked and apparently identical subunits of I%& 90000. Using an affinity purified, polyclonal 
rabbit antibody, we have studied the in vitro biosynthesis of this receptor. The primary translation 
product, synthesised in a rabbit reticulocyte lysate programmed with human placental RNA, appears to 
have the same M, (78 000) as the unglycosylated molecule immunoprecipitated from tunicamycin-treated 
cells. In the presence of a dog pancreatic microsomal system the cell free system accurately reproduces the 
glycosylation and the asymmetric transmembrane i tegration 
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1. INTRODUCTION 
The in vitro synthesis of many secretory proteins 
and of some membrane glycoproteins has been 
studied in detail [ 1,2]: a cell-free system reproduc- 
ed cell features required for the synthesis of pro- 
tein and its insertion into the endoplasmic 
reticulum. 
Here, we examine the in vitro biosynthetic pro- 
duct from rabbit reticulocyte lysate programmed 
with human placental RNA. Using an affinity 
purified polyclonal antibody raised in a rabbit 
against the SDS-PAGE purified, reduced and 
alkylated transferrin receptor, we characterise the 
in vitro synthesised molecule and follow its pro- 
cessing and membrane insertion. 
We have used a monoclonal antibody (OKT9) to 
study the human, cell-surface receptor for 
transferrin. This receptor is a transmembrane 
phospho-glycoprotein composed of two 
disulphide linked subunits of 90 kDa. It has 3 
asparagine-linked glycan chains [3] and covalently- 
bound fatty acid [4]. Many of these features are 
common to other membrane glycoproteins (e.g., 
H-2, HLA, viral glycoproteins) for which details 
of in vivo and in vitro biosynthesis are known 
[5,61. 
2. MATERIALS AND METHODS 
Human placentas were obtained from University 
College Hospital, London (courtesy of Professor 
Fairweather). 
2.1. Preparation of anti-transferrin receptor 
antibody 
Abbreviations: SDS-PAGE, sodium dodecyl 
sulphate-polyacrylamide gel eleetrophoresis; PBS, 
phosphate-buffered saline; DTT, dithiothreitol; 
NEN,N-ethyl maleimide; Mr N relative molecular mass 
Transferrin receptor was purified from foetal 
liver or placenta by cross-linked immunoaffinity 
chromatography [7]. The eluate from the affinity 
column was dialysed against PBS containing 1% 
SDS, concentrated by pressure dialysis, reduced in 
the presence of 20 mM DTT at 100°C for 4 min, 
cooled at 4°C and alkylated by adding 70 mM 
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NEM for 2 h at 4°C [8], The sample was then 
separated after boiling in SDS sample buffer con- 
taining 1% ~-mercaptoethanol, by preparative 
SDS-PAGE on 7% polyacryl~ide, 2 mm thick 
slab gels [9]. At the end of the run the gels were 
stained in Coomassie brilliant blue 0.2% (w/v) - 
water for 30 min and destained in water. The band 
containing the transferrin receptor was cut out, 
homogenised in 1 ml PBS and emulsified in 1.5 ml 
complete Freund’s adjuvant. Equivalents 1OOpg of 
transferrin receptor were injected subcutaneously 
into 15 sites on the back of a female New Zealand 
rabbit. Booster injections in incomplete Freund’s 
adjuvant were given at 1 week intervals for 3 
weeks. The rabbits were boosted after a further 
month and bled 2 weeks later. 
2.2. Affinity purification of rabbit antibodies to 
denatured tra~ferrin receptor 
Transferrin receptor was purified by gel elec- 
trophoresis as above. The gel slices were 
homogenised and extracted overnight in 1% Li- 
dodecylsulphate (LDS), 1 M LiCl, 50 mM 
triethanolamine (TEA) (pH 7.5). After overnight 
dialysis the material containing about 500 ag pure 
transferrin receptor was added to 500 mg Eupergit 
C according to the manufacturer’s protocol (Rohm 
Pharma Weiterstadt). Aliquots (1 ml) of the rabbit 
serum were passed through the column and after 
washing the column with 10 column vol. (30 ml) of 
PBS containing 0.05~0 NP40, the antibody was 
eluted by 0.1 M HCI and immediately neutralised 
with Tris to pH 7.0. It was dialysed overnight 
against PBS and stored in 0.2% gelatin at - 20°C. 
2.3 Preporut~on f RNA 
Placental tissue was washed in cold PBS several 
times to remove blood, and then homogenised in 7 
M urea-3 M LiCl in a Sorvall-omnimixer for 3 min 
at 1 g of tissue/l0 ml LiCl-urea solution. The 
homogenate was left overnight at 4°C and then 
centrifuged at 10000 x g in a SS-34 Sorvall for 20 
min. The pellet was extracted twice with 
phenol-chloroform (1: 1, v/v) and the final 
aqueous layer was made 0.2 M in ammonium 
acetate (pH 5) and 70% in ethanol, and left at 
- 20°C. 
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2.4 Cell-free translation 
Rabbit reticulocyte was used as recommended 
by the supplier [New England Nuclear (NEN) 
Boston MA] and supplemented with 6 mM 
2-aminopurine. Total RNA (15 pg) was added for 
each 25 pl translation mixture. After translation 
for 90 min at 31”C, the reaction was stopped by 
adding 1 vol. 2% SDS in 10 mM EDTA (pH 7.4) 
and immediately boiled at 100°C for 1 min. When 
dog pancreatic microsomal membranes were used 
(also obtained from NEN), the reaction mixture 
was instead layered on 5% sucrose in 0.1 N NaOH 
and centrifuged at 100000 x g in a Beckman air- 
fuge for 30 min. The pellet (containing the mem- 
branes) was resuspended in 1% SDS-IO mM 
EDTA and immediately boiled at 100°C for 3 min. 
2.5. Trypsin digestion 
For the post-translational trypsin digestion of 
the products synthesised in the presence of dog 
pancreatic ~crosomes, the reaction was stopped 
by adding CaClz to a final concentration of 5 mM. 
The trypsin was added at 500 fig/ml to 5 x 25 ~1 
reaction mixture and left at 4°C for 1 h. Digestion 
was terminated by addition of soybean trypsin in- 
hibitor (5 mg/ml) and EDTA 10 mM followed by 
SDS solubilisation. 
2.6. Immunoprecipitation 
Lysate (150 pl; 3 x 25 pl lysate equivalents; see 
section 2.4) was diluted 6-fold in 2.5% NP40 200 
mM NaCl, 50 mM Tris, 5 m&I EDTA, 0.02qo 
NaNs. Normal rabbit serum (10 ~1) was added and 
after 1 h at 4”C, 100 pl of heat-killed, formalin- 
fixed Staphylococcus aureus Cowan I strain (SaCl) 
was added and left for a further 30 min. The 
bacteria were pelleted in an Eppendorf microfuge 
and the preclearance was repeated twice. Finally, 
20 ~1 of affinity-purified antibodies (about 5 ag of 
pure antibody) were added together with 5 mg 
cytochrome c 0.5 M NaCl. The antibodies were left 
overnight at 4°C and then precipitated by adding 
50 pl of a 50% protein A Sepharose4BCl slurry 
for 30 min. The beads were washed twice in 1 ml 
of 0.5 M NaCl, 10 mM Tris, 0.5% NP40 and once 
in 0.15 M NaCl, 10 mM Tris (pH 8.1), 0.5% NP40, 
0.1% SDS boiled for 2 min in gel sample buffer [9] 
and supernatants analysed by SDS-PAGE [9] and 
fluorography [ 1 I 1. 
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2.1. Endoglycosidase (end&T.) digestion 
HSB-2 cells (a T-lymphoblastoid cell-line) were 
pulse-labelled with [35S]methionine for 10 min. 
Cell lysis and immunoprecipitation with OKT9 was 
performed as in 131. When rabbit antibody was 
used, the cell lysate was adjusted to 1% (w/v) SDS 
and boiled at 100°C for 1 min as above. Processing 
of immune complexes and endo-H digestion were 
performed as in 112, 131. 
2.8 Tunicamycin treatment 
Washed HSB-2 cells were suspended in 
methionine-free Eagle’s E4 medium (5 x 106/ml) 
supplemented with tunicamycin (a gift from Dr 
Hamill, Ely Lilly Corp.) at 10 pglml. The cells 
were incubated at 37°C for 2 h before addition of 
[3SS]methionine (4mCi/lO* cells) and then further 
incubated for 10 min or 2 h before extraction and 
immune complex formation with specific anti- 
bodies as above. 
3. RESULTS 
3.1. Identification of the transferin receptor as 
synt~esised in vitro 
A rabbit antiserum to the purified, denatured 
transferrin receptor subunit was produced as in 
section 2. This antiserum was shown to immuno- 
precipitate the transfertin receptor from SDS- 
denatured lysates labelled with [35S]methionine 
(fig. lA, track a); the characteristics are the same 
as that immunopre~pitated by the monoclon~ 
antibody OKT9 [3]. The rabbit antibody was in 
some respects a superior reagent for analysing the 
tunicamycin-treated form of the receptor as the 
‘denaturing’ treatment of the cell lysate seemed to 
clear the background of non-speci~c~ly immuno- 
precipitated (presumably aggregated) labelled 
proteins. 
The in vitro synthesis of the transferrin receptor 
subunit could be demonstrated by immuno- 
precipitation of total translation products from a 
rabbit reticulocyte lysate programmed with human 
placental RNA. This primary translation product 
has the same app. Mr (-78 000; fig. lB, track c) as 
the polypeptide immunoprecipitated from cells 
pulse-labelled for 10 min in the presence of 
tunicamycin (fig. lB, track b). When cells are 
labelled for 2 h in the presence of tunic~ycin, 
Fig. 1. Autoradiograph of [35S]methionine-labelled 
transferrin receptor immunoprecipitated with affinity- 
purified rabbit antibody. (A) Immunoprecipitates from 
HSB-2 cells [‘-%]methionine labelled for 2 h in the 
absence (track a) or in the presence (track b) of 10 fig 
tunicamycinlml. Immunoprecipitate of transferrin 
receptor synthesised in vitro in the absence (track c) or 
in the presence (track d) of dog pancreas microsomal 
membranes (membranes were pelleted through a 5% 
sucrose Iayer/O. 1 N NaOH and solubihsed in I % SDS). 
HSB-2 cefls were pulse-ia~ll~ for 10 min with 
[35S)methionine: the immunoprecipitat~ transferrin 
receptor (track e) was digested with 0.1 mV (track f) or 
1 mV (track h) of endoglycosidase-H. Transferrin recep- 
tor synthesised in vitro in the presence of dog pancreas 
microsomal membranes was digested with 1 mV of 
endoglycosidase-H (track g). AI1 samples were rnn on a 
gradient gel of 7-12070 acrylamide. (B) Transferrin 
receptor immunoprecipitated from HSB-2 ceils labelled 
for 10 min in the absence (track a) or in the presence 
(track b) of 10,~g tunicamycin/ml. Track c, transferrin 
receptor immunoprecipitated from in vitro-translated 
placental RNA. All samples were run on 8% 
SDS-polyac~lamide gel, 30 cm long. 
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another polypeptide is immunoprecipitated (fig. 
lA, track b); the lower band, probably represent- 
ing the non-glycosylated, membrane-inserted 
precursor, has the same M, as the in vitro primary 
translated product (fig. lA, track c). 
3.2. In vitro glycosylation and membrane 
insertion 
Core glycosylation to the high mannose precur- 
sor can be faithfully reproduced in the cell-free 
system by including rough microsomal vesicles 
from dog pancreas in the translation reaction [14, 
151. When such microsomes are present during 
translation of placental RNA, the Mr 78000 
primary translation product (fig. lA, track c) is 
converted into a series of 3 higher Mr polypeptides 
(fig. lA, track d). The largest of these has an app. 
iI4 85 000 which is indistinguishable from the core 
glycosylated (high mannose) molecule im- 
munoprecipitated from an in vivo pulse labelled 
HSB-2 cell lysate (fig. IA, track e). The oligoman- 
nosy1 cores of the immature glycoprotein can be 
cleaved by the enzyme endoglycosidase-H; diges- 
tion yields polypeptides containing only the prox- 
imal N-acetyl glucosamine residues [12]. When the 
in vitro product synthesised in the presence of dog 
pancreas microsomes is digested with a supraop- 
timal concentration of endoglycosidase-H, the 
polypeptide which is produced (fig. lA, track g) 
has the same MI as the 10 rnin in vivo pulse-labelled 
molecule treated in parallel with endo-H (fig. lA, 
track h). In addition, the two digested products 
comigrate at the same position in a two- 
dimensional isoelectric focusing/SDS-PAGE gel 
system (not shown). 
The other polypeptides present in the in vitro 
product synthesised in the presence of dog pan- 
creas microsomes (fig. lA, track d) correspond to 
the stepwise addition of oligomannosyl core units. 
Treating the in vivo synthesised molecule im- 
munoprecipitated after a 10 min pulse with sub- 
optimal concentration of endoglycosidase-H 
results in a similar pattern of intermediate bands 
(fig. lA, track f). 
Insertion of the translated product into the 
rough endoplasmic reticulum could be reproduced 
in the cell free system by including dog pancreas 
microsomes in the translation reaction. The 
translation mixture containing the dog pancreas 
microsomes was pelleted through a 5% sucrose 
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layer containing 0.1 N NaOH. This treatment 
strips off all the extrinsic non-integrated synthesis- 
ed proteins but the transferrin receptor subunit can 
still be immunoprecipitated from the solubilised 
pellet. Proof that the products were co- 
translationally integrated into the dog pancreas 
microsomal membranes in a transmembrane con- 
figuration comes from an experiment in which the 
post-translational products were incubated with 
trypsin. Each of the intact, membrane integrated 
polypeptides (fig. 2, track b) appeared to be 
digested to a corresponding membrane-protected 
Fig. 2. Transferrin receptor immunoprecipitated with 
the rabbit antibody from a reticulocyte lysate translation 
system in the absence (track e) or in the presence (track 
b) of dog pancreas microsomal membranes during 
translation of human placental RNA. Track (c), in vitro 
translation of placental RNA in the presence of dog pan- 
creas microsomes followed by trypsin digestion (section 
2) and immunoprecipitation of the transferrin receptor. 
Track d, in vivo synthesised transferrin receptor after 
immunoprecipitation with monoclonal antibody 0KT9 
from a 10 min labelled [35S]methionine HSB-2 cell lysate 
and (track a) digestion of the same with 1 mV of 
endoglycosidase-H. All samples were run on a gradient 
gel of 7-12% acrylamide. 
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fragment Mr 78000 reduced in size by about 6 
kDa/fig. 2, track c). This trypsin cleavage product 
is easily distinguishable from the one obtained by 
treating detergent-lysed [35S]methionine pulse- 
labelled cells with trypsin (MI 67 000; not shown). 
In fact, there is a trypsin-sensitive cleavage site on 
the extracellular facing side of the mature molecule 
which originates a M, 70 000 trypsin-resistant frag- 
ment [3]. 
4. DISCUSSION 
Here, we have examined the cell free synthesis, 
glycosylation and membrane insertion of the 
human cell surface receptor for transferrin. This 
membrane protein exists as a disulphide-linked 
dimeric complex. It has been assumed, although 
no direct proof exists, that the two A& 90000 
subunits are identical [3]. The data reported here 
are in accord with this interpretation since only one 
major primary translation product could be 
detected. 
It is now well established that secretory proteins 
and some membrane proteins are synthesised on 
polyribosomes bound to the endoplasmic 
reticulum. The formulation and subsequent 
elaboration of the signal hypothesis [l] has led to 
the view that the specificity of this interaction is 
associated with the amino-terminal sequence of the 
nascent chain, usually associated with the presence 
of a detachable, hydrophobic ‘signal’ sequence. 
There appears to be no absolute requirement for a 
detachable signal sequence, as ovalbumin, and 
some membrane proteins such as rhodopsin 1161 
and Escherichia coli lactose permease [171 are syn- 
thesised and exported without removal of a 
peptide. 
We were not able to detect a difference in M, for 
the primary translation product of the transferrin 
receptor synthesised in a cell free system that might 
reflect the existence of a detachable signal peptide; 
i.e., the ‘in vivo’ unglycosylated, but membrane- 
inserted protein, (immunoprecipitated from pulse- 
labelled cells preincubated in tunicamycin), had 
the same relative mobility as the primary transla- 
tion product. Furthermore, by adding dog pan- 
creas microsomes, no apparent processing to a 
smaller M,, representing the integrated, 
unglycosylated and signal sequence cleaved in- 
termediate, could be detected. 
Our failure to detect such a difference in relative 
mobility representing a cleavable signal peptide 
could be explained as: 
(i) The possible increase of hydrophobicity con- 
tributed by the signal peptide resulting in in- 
creased SDS-binding and a higher mobility of 
the protein in SDS-PAGE; the resulting small 
difference in mobility may not be resolvable by 
this technique; 
(ii) The possibility that the precursor peptide is re- 
tained in vivo in the presence of tunicamycin as 
suggested in the case of the IgM p chain [ 181. 
Explanation (ii) seems unlikely, since the same 
result is obtained in a 10 min pulse or a 2 h label- 
ling in the presence of tunicamycin; furthermore 
the polypeptide so obtained has an M, - 500 lower 
than the endo-H-treated high-mannose form of the 
molecule, accounting for 3 N-acetylglucosamine 
residues still remaining after digestion. Alter- 
natively, the transferrin receptor may provide 
another example of a membrane protein with no 
cleavable signal sequence. At present we cannot 
distinguish between these interpretations. Sequenc- 
ing of cloned cDNA corresponding to the transfer- 
rin receptor mRNA should provide a definitive 
answer. 
Finally, we were able to demonstrate the mem- 
brane integration and glycosylation of the transfer- 
rin receptor in vitro by adding dog pancreas 
microsomes to the reticulocyte lysate. Both pro- 
cesses appeared to be identical to the ‘in vivo’ 
biosynthesis of the receptor. Due to the slower 
kinetics of the in vitro system it was possible to 
identify all the intermediates in the core glycosyla- 
tion process, including a population of non- 
glycosylated molecules. 
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